Shukra Pharmaceuticals Ltd

Shukra Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shukra Pharmaceuticals Ltd

₹ 28.0 -3.38%
25 May - close price
shukrapharmaceuticals.com BSE: 524632
About

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing[1]

Key Points

Business Overview:[1][2]
SPL is a is WHO-GMP certified integrated manufacturer of formulations like tablet, capsules and small volume parenteral. It has assisted in the development and manufacture
of a variety of drugs and dosage forms and potency variations for many pharmaceutical companies

Website BSE
  • Market Cap ₹ 1,227 Cr.
  • Current Price ₹ 28.0
  • High / Low ₹ 65.3 / 12.8
  • Stock P/E 55.6
  • Book Value ₹ 2.05
  • Dividend Yield 0.04 %
  • ROCE 36.9 %
  • ROE 28.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 13.7 times its book value
  • Debtor days have increased from 123 to 148 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2024 Mar 2025 Sep 2025 Dec 2025 Mar 2026
10.58 13.27 5.88 39.13 6.32
6.65 5.96 6.29 12.00 5.62
Operating Profit 3.93 7.31 -0.41 27.13 0.70
OPM % 37.15% 55.09% -6.97% 69.33% 11.08%
1.01 1.47 1.71 0.82 0.95
Interest 0.15 0.27 0.29 0.28 0.26
Depreciation 0.70 0.94 0.81 0.84 1.01
Profit before tax 4.09 7.57 0.20 26.83 0.38
Tax % 22.74% 28.80% -1,090.00% 24.08% 552.63%
3.16 5.39 2.38 20.36 -1.72
EPS in Rs 0.07 0.12 0.05 0.46 -0.04
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
33 57
20 28
Operating Profit 13 29
OPM % 39% 51%
4 5
Interest 1 1
Depreciation 3 3
Profit before tax 13 29
Tax % 28% 23%
10 22
EPS in Rs 0.22 0.50
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 74%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 130%
Stock Price CAGR
10 Years: 55%
5 Years: 138%
3 Years: 121%
1 Year: 111%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 29%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 44 44
Reserves 19 46
4 5
20 23
Total Liabilities 87 117
19 22
CWIP 2 12
Investments 0 0
65 84
Total Assets 87 117

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
8 4
-1 -14
-5 4
Net Cash Flow 2 -6
Free Cash Flow 5 -12
CFO/OP 92% 19%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Debtor Days 98 148
Inventory Days 447 320
Days Payable 414 232
Cash Conversion Cycle 131 236
Working Capital Days 403 352
ROCE % 37%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtors Turnover Ratio
Ratio ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
Number ・Standalone data
Manufacturing Facility Land Size
Acres ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
50.90% 50.90% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95% 50.95%
0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
48.99% 48.99% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.93% 48.92%
No. of Shareholders 9,5829,74710,96312,97414,98916,32117,84418,23120,33721,44125,64927,173

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports